MEDMEDIFAST INC

NYSE medifastinc.com


$ 25.48 $ 0.33 (1.31 %)    

Tuesday, 07-May-2024 15:59:56 EDT
QQQ $ 440.32 $ 0.07 (0.02 %)
DIA $ 388.70 $ 0.29 (0.07 %)
SPY $ 517.26 $ 0.57 (0.11 %)
TLT $ 90.79 $ 0.55 (0.61 %)
GLD $ 214.23 $ -0.99 (-0.46 %)
$ 25.51
$ 25.24
$ 0.00 x 0
$ 0.00 x 0
$ 24.66 - $ 25.63
$ 24.58 - $ 107.29
508,782
na
279.54M
$ 1.21
$ 4.13
TBD
na
na ($ 0.26)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-29-2024 03-31-2024 10-Q
2 02-20-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-01-2023 03-31-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-02-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-03-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 03-02-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 03-01-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-06-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 03-16-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-16-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-15-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 03-16-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 da-davidson-maintains-neutral-on-medifast-lowers-price-target-to-25

DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Neutral and lowers the price target from $40 to...

 medifast-expects-q2-revenue-of-150m-170m-est-17510m-eps-of-005-040-est-067

The EPS range excludes the costs related to the initiation of the LifeMD collaboration and any gains or losses from changes in ...

 medifast-q1-2024-adj-eps-066-misses-078-estimate-sales-174739m-beat-168900m-estimate

Medifast (NYSE:MED) reported quarterly earnings of $0.66 per share which missed the analyst consensus estimate of $0.78 by 15.3...

Core News & Articles

On March 06, 2024, Nu Skin Enterprises (NYSE:NUS) will distribute a dividend payout of $0.06 per share, equating to an annualiz...

 why-international-flavors--fragrances-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported m...

 da-davidson-maintains-neutral-on-medifast-lowers-price-target-to-40

DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Neutral and lowers the price target from $67 to...

 palo-alto-networks-issues-weak-outlook-joins-teladoc-health-solaredge-technologies-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 70 points on Wednesday.

 recap-medifast-q4-earnings
Recap: Medifast Q4 Earnings
02/20/2024 21:10:26

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION